205 related articles for article (PubMed ID: 25926832)
1. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.
Specht HM; Ahrens N; Blankenstein C; Duell T; Fietkau R; Gaipl US; Günther C; Gunther S; Habl G; Hautmann H; Hautmann M; Huber RM; Molls M; Offner R; Rödel C; Rödel F; Schütz M; Combs SE; Multhoff G
Front Immunol; 2015; 6():162. PubMed ID: 25926832
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.
Gunther S; Ostheimer C; Stangl S; Specht HM; Mozes P; Jesinghaus M; Vordermark D; Combs SE; Peltz F; Jung MP; Multhoff G
Front Immunol; 2015; 6():556. PubMed ID: 26579130
[TBL] [Abstract][Full Text] [Related]
3. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
4. Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
Multhoff G; Seier S; Stangl S; Sievert W; Shevtsov M; Werner C; Pockley AG; Blankenstein C; Hildebrandt M; Offner R; Ahrens N; Kokowski K; Hautmann M; Rödel C; Fietkau R; Lubgan D; Huber R; Hautmann H; Duell T; Molls M; Specht H; Haller B; Devecka M; Sauter A; Combs SE
Clin Cancer Res; 2020 Oct; 26(20):5368-5379. PubMed ID: 32873573
[TBL] [Abstract][Full Text] [Related]
5. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.
Kokowski K; Stangl S; Seier S; Hildebrandt M; Vaupel P; Multhoff G
Strahlenther Onkol; 2019 Apr; 195(4):352-361. PubMed ID: 30747241
[TBL] [Abstract][Full Text] [Related]
6. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
Bashiri Dezfouli A; Yazdi M; Benmebarek MR; Schwab M; Michaelides S; Miccichè A; Geerts D; Stangl S; Klapproth S; Wagner E; Kobold S; Multhoff G
Front Immunol; 2022; 13():883694. PubMed ID: 35720311
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
Moser C; Schmidbauer C; Gürtler U; Gross C; Gehrmann M; Thonigs G; Pfister K; Multhoff G
Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481
[TBL] [Abstract][Full Text] [Related]
8. Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells.
Stangl S; Wortmann A; Guertler U; Multhoff G
J Immunol; 2006 May; 176(10):6270-6. PubMed ID: 16670338
[TBL] [Abstract][Full Text] [Related]
9.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
Milani V; Stangl S; Issels R; Gehrmann M; Wagner B; Hube K; Mayr D; Hiddemann W; Molls M; Multhoff G
J Transl Med; 2009 Jun; 7():50. PubMed ID: 19549307
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells.
Kleinjung T; Arndt O; Feldmann HJ; Bockmühl U; Gehrmann M; Zilch T; Pfister K; Schönberger J; Marienhagen J; Eilles C; Rossbacher L; Multhoff G
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):820-6. PubMed ID: 14529789
[TBL] [Abstract][Full Text] [Related]
12. Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck.
Gehrmann M; Specht HM; Bayer C; Brandstetter M; Chizzali B; Duma M; Breuninger S; Hube K; Lehnerer S; van Phi V; Sage E; Schmid TE; Sedelmayr M; Schilling D; Sievert W; Stangl S; Multhoff G
Radiat Oncol; 2014 Jun; 9():131. PubMed ID: 24912482
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70-Derived Peptide: A Combined Computational and Experimental Study.
Yazdi M; Hasanzadeh Kafshgari M; Khademi Moghadam F; Zarezade V; Oellinger R; Khosravi M; Haas S; Hoch CC; Pockley AG; Wagner E; Wollenberg B; Multhoff G; Bashiri Dezfouli A
Adv Sci (Weinh); 2024 Apr; 11(14):e2305998. PubMed ID: 38298098
[TBL] [Abstract][Full Text] [Related]
14. Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody.
Stangl S; Gehrmann M; Riegger J; Kuhs K; Riederer I; Sievert W; Hube K; Mocikat R; Dressel R; Kremmer E; Pockley AG; Friedrich L; Vigh L; Skerra A; Multhoff G
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):733-8. PubMed ID: 21187371
[TBL] [Abstract][Full Text] [Related]
15. Elevated Levels of Circulating Hsp70 and an Increased Prevalence of CD94+/CD69+ NK Cells Is Predictive for Advanced Stage Non-Small Cell Lung Cancer.
Seier S; Bashiri Dezfouli A; Lennartz P; Pockley AG; Klein H; Multhoff G
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428793
[TBL] [Abstract][Full Text] [Related]
16. A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity.
Multhoff G; Pfister K; Gehrmann M; Hantschel M; Gross C; Hafner M; Hiddemann W
Cell Stress Chaperones; 2001 Oct; 6(4):337-44. PubMed ID: 11795470
[TBL] [Abstract][Full Text] [Related]
17. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
Yang YJ; Park JC; Kim HK; Kang JH; Park SY
Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation improves glioma-specific targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 monoclonal antibodies (SPION-cmHsp70.1).
Shevtsov MA; Nikolaev BP; Ryzhov VA; Yakovleva LY; Marchenko YY; Parr MA; Rolich VI; Mikhrina AL; Dobrodumov AV; Pitkin E; Multhoff G
Nanoscale; 2015 Dec; 7(48):20652-64. PubMed ID: 26599206
[TBL] [Abstract][Full Text] [Related]
19. Role of membrane Hsp70 in radiation sensitivity of tumor cells.
Murakami N; Kühnel A; Schmid TE; Ilicic K; Stangl S; Braun IS; Gehrmann M; Molls M; Itami J; Multhoff G
Radiat Oncol; 2015 Jul; 10():149. PubMed ID: 26197988
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.
Park TS; Kim HR; Koh JS; Jang SH; Hwang YI; Yoon HI; Chung JH; Kim CH; Kim SS; Kim WS; Jo J; Lee JC; Choi CM
Lung Cancer; 2014 Nov; 86(2):262-7. PubMed ID: 25261232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
